SAR 247799Alternative Names: SAR-247799
Latest Information Update: 08 Nov 2016
At a glance
- Originator Sanofi
- Class Small molecules
- Mechanism of Action Sphingosine 1 phosphate receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Cardiovascular disorders
Most Recent Events
- 28 Oct 2016 Phase-I clinical trials in Cardiovascular disorders in France (unspecified route)